Pharmaceutical

Misr Company For Pharmaceuticals

Modifications

2026

Year

Misr Company For Pharmaceuticals

Misr Company For Pharmaceuticals engaged MIDEX to carry out modifications to its distiller unit at its facility in Obour City.

The challenge

The distiller unit required modifications to maintain reliable Water for Injection (WFI) generation performance.

Our approach

MIDEX assessed the distiller, engineered the required modifications, and carried out the works with performance verification.

Project scope

Distiller Modification. Location: Obour City. Year of implementation: 2026.

Key deliverables

  • Distiller assessment
  • modification engineering and execution
  • testing and performance verification
  • documentation handover

Outcome

The modified distiller unit continues to reliably generate WFI for Misr Company For Pharmaceuticals at the site.